CHMP recommends granting of marketing authorization for Orphan Europe's Vedrop June 11, 2009 No Comments
EMEA provides information on possible interaction between clopidogrel and PPIs June 9, 2009 No Comments
Sepracor withdraws marketing authorization application for Lunivia (eszopiclone) May 19, 2009 No Comments
CHMP recommends marketing authorization for Astellas' Modigraf in transplant rejection March 24, 2009 No Comments
CHMP recommends marketing authorization for HRA's emergency contraceptive ellaOne March 24, 2009 No Comments
Bristol-Myers Squibb withdraws marketing authorization application for Ixempra March 23, 2009 No Comments
RSS